This came in the other day. They are looking correct today. COVID-19 Vaccine Sends Stock Soaring 1,000% — Huge Potential
Ahead With Global WholeHealth Partners (GWHP)!
Here we go, GWHP is breaking out to the upside very fast this morning.
If you haven't taken a look at this stock yet, this is your chance. Make sure you have GWHP pulled up on your trading screen.
Technical Analysis
#1.) The previous close was $1.10/share
#2.) The 1st Resistance Point Was - $1.16
#3.) The 2nd Level Resistance Point Was - $1.22
#4.) The 14 Day RSI at 80% - $3.24
The Next Technical Breakout Point Represents 165% Upside.
For anyone that may have missed my email from earlier, I've included a copy below.
The Street is Taking Notice of this Emerging Player in
the Hyper-Growth Covid-19 Diagnostics Space!
There’s finally some good news about the global pandemic.
On Monday, shares of "Pfizer Inc. (NYSE: PFE)" Sky-rocketed up in price on the coat-tails of Covid-19 Vaccine.
Turn your full attention to another COVID-19 stock set to surge in price practically overnight according to several Wall Street analysts.
This little-known $1.25/share COVID-19 medical diagnostics company manufactures & distributes rapid antigen test kits for our country.
The U.S Navy base in California was one of the very first buyers of their serologic rapid blood test that detects the virus in under 15 minutes flat.
I know for a FACT you’re looking for the biggest gains, small companies positioned to disrupt massive industries have the greatest potential to skyrocket.
A stock like this has the potential to turn a $10,000 investment into $166,000 in just one year?
So be sure you read the research reports below, to see why two analysts predict a staggering price target on GWHP....10X gains in as little as 12 months.
Immediately turn your attention to Global WholeHealth Partners (GWHP)
This is our next breakout stock ready to move in a major way, here's why...
If you had bought 25,000 shares of my previous Covid-19 diagnostics stock Co-Diagnostics when I had first initiated coverage on it at $.85/share and sold it at its high of $30.99/share, you'd be sitting on approx. $750,000 right now.
My track record for Covid-19 related stock trades has dished out 3,545% gains with my previous Covid-19 diagnostics alert which ran from $.85 to $30.99 following a favorable response to its EUA earlier this year, reaching a peak valuation of 20x next years EPS.
Using A Similar Multiple On GWHP, Investment Research Analyst
Projects GWHP Could Reach $11.20 – Which is 1,000% Upside Potential!
Using a similar multiple on my newest Covid-19 diagnostics stock GWHP, Investment Research Analyst Rob Goldman at Goldman Small Cap Research projects GWHP could reach $11.20.
If you missed my previous Covid-19 related profile run from $.85 to $30, here is your second chance with my newest Covid-19 diagnostics stock GWHP.
The Street is Taking Notice of this Emerging Player in
the Hyper-Growth Covid-19 Diagnostics space!
Headlines about the "global health crisis" continue to dominate as the "second wave" of Covid-19 Hits the country.
With no signs of the 'virus' slowing down yet, the demand for Rapid Diagnostic Test (“RDT”) and Real Time Polymerase Chain Reaction Test (“RT-PCR”) has been Skyrocketing!
And that brings me to Mondays alert GWHP, which could easily dish out some of the BIGGEST GAINS of 2020, with its 1,000% in upside potential!
It's important to note Global WholeHealth Partners has a history of experiencing increased upside potential, and has presented investors with considerable upside multiple times and may be positioned for a new round of gains.
Analyst are bullish on GWHP, following their Blockbuster News!
You must take this particular pick very serious, pay close attention to the magnitude of their latest Blockbuster News, GWHP now offers the New “FDA” Cleared Fingerstick for Rapid Covid-19 Test, get results in minutes (with the "Only FDA Authorized") Covid-19 POC serology Test.
GWHP Bullish Catalysts – Multiple Breakout Catalysts
Signaling Breakout Gain Potential
CATALYST #1 Potential Breakout Catalyst – Breaking Global WholeHealth Partners (GWHP) Now Offers the New “FDA” Cleared Fingerstick for Rapid Covid-19 Test, Results in Minutes (with the "Only FDA Authorized") Covid-19 POC serology Test.
With several bullish catalysts working in GWHP favor, I believe that the next big breakout could be potentially about to take place.
....GWHP has been the subject of a number of investment research analyst reports!
GWHP Bullish Catalysts – Multiple Analyst Ratings
Signaling Breakout Gain Potential
CATALYST #2 Potential Breakout Catalyst – Breaking Investment Research Analyst Rob Goldman at Goldman Small Cap Research issued analyst coverage on Global WholeHealth Partners (GWHP), issuing a $11.20/share Price Target, Representing an approx. 1,000% Upside Potential.
In the Investment Research report below, analyst Rob Goldman discusses the major sales for Covid-19 test kits and the potential impact on the Company and its valuation.
Image
Taglich Brothers Initiates Coverage of Global WholeHealth Partners (GWHP)
Investment Research Analyst Howard Halpren Issued Speculative Buy!
CATALYST #3 Potential Breakout Catalyst – Breaking Taglich Brothers Initiates Coverage of Global WholeHealth Partners and Investment Research Analyst Howard Halpren Issued Speculative Buy.
In the Investment Research Report Below, Taglich Brothers Analyst Howard Halpren Issued Speculative BUY, analyst Howard Halpern discusses Global WholeHealth Partners penetrating rapid COVID-19 diagnostic testing market given that it has three COVID-19 diagnostic tests submitted and pending for FDA emergency use approval.
Image
Huge Breakthrough For GWHP Receives "FDA" Acknowledgement
Letter for Its "Antigen Rapid Test" For COVID-19!
CATALYST #4 Potential Breakout Catalyst – Huge Breakthrough For GWHP Receives "FDA" Acknowledgement Letter for Its "Antigen Rapid Test" For Covid-19!
The Antigen test is a"Game Changer" because the test reveals if a person is "currently" infected with a pathogen such as the SARS-CoV-2 virus. Once the infection has gone, the antigen disappears.
GWHP Rapid Diagnostic Testing (RDT) Whole Blood, Serum /Plasma Can Detect Between 15 -20 Minutes, Which Predict Diseases Ahead Of Its Industry Competitors.
My Track Record for Covid-19 related stock trades has dished out 3,545% gains with my previous Covid-19 Diagnostics stock — Co-Diagnostics (CODX) is a company that I had previously covered from my initial alert on July 2, 2019 at $.85/share all the way to its 52 week high of $30.99/share on Aug 3rd, following a favorable response to its EUA earlier this year, reaching a peak valuation of 20x next years EPS... providing my "loyal members with 3,545% Gains."
Using A Similar Multiple On GWHP, Investment Research Analyst
Projects GWHP Could Reach $11.20 – Which is 1,000% Upside Potential!
Follow Me Closely Here, if you missed my previous profile run from $.85 to $30.99 booking a staggering 3,545% gains, here is your second chance with my newest Covid-19 diagnostics stock Global WholeHealth Partners (GWHP).
If their $11.20 price target is indicative of what's to come, we could see potential gains of up to 1,000% according to Investment Research Analyst Rob Goldman at Goldman Small Cap Research!
If you haven't taken a look at this stock yet, this is your chance. Make sure you have GWHP pulled up on your trading screen...It could be headed towards a potential $11.20/share, according to analysts.
“The Company’s goal is to offer the fastest and most reliable in-vitro diagnostic tests on the market, while keeping ahead in R&D, by offering FDA Approved Troponin I Whole Blood, Nasal Swab Influenza A & B, and Throat Swab Strep A, Urine and Saliva Drug Testing, Whole Blood Mononucleosis, H. Pylori, FOB, and several other tests.”
Global WholeHealth Partners Corporation (GWHP)
The Next Major Covid-19 Diagnostics Breakout Company!
GWHP is set to emerge as a major provider of COVID-19 rapid diagnostics test kits, disrupting the "BOOMING" $5.1 Billion COVID-19 Diagnostics Market... which could be the best way to potentially play one of the year’s hottest sectors.
At this point we have very high expectations for this revolutionary company, seeing its backed by multiple analysts’ one of which strongly believes it could potentially reach $11.20!
>>> Six Key Investment Highlights That Could Potentially Send
Shares Soaring, Combined With its 1,000% Upside <<<
Goldman Small Cap Research Analyst Issued $11.20/share Price Target.
Taglich Brothers Analyst Howard Halpren Issued Speculative BUY.
Founded in 1991, Taglich Brothers, Inc. is a full-service brokerage firm specializing in the microcap segment of the market for publicly traded securities.
In studies performed earlier this year, GWHP’s diagnostic antibody test produced such an enviable accuracy rate that the Department of the Navy placed an order for 1000 kits. The test’s accuracy was found to be over 97%, with limited false positives, a major differentiator.
If you missed the CODX run from $3 to $30, here is your second chance to research GWHP.
GWHP is set to emerge as a key provider of COVID-19 diagnostics test kits, an estimated $5.1BIL market. The Company has filed two Emergency Use Applications (EUAs) with the FDA—one for an anti-body test and the other for a rapid global antigen test, with responses pending.
>>> Five Competitive Advantages <<<
GWHP clearly has advantages as compared to other manufactures in the space. Its proprietary COVID-19 test kit pending EUA approval boasts high sensitivity and specificity results that ensure lower false positives than many approved kits in use today.
GWHP rapid blood test kit can detect antibodies in 15 minutes---one of the fastest times which can aid in overall testing throughout the country.
GWHP is one of the few manufactures that has submitted multiple applications to the FDA for diagnostic testing.
GWHP recently submitted a new EUA with the FDA for a Global Antigen CoViD19 SARS2 Rapid Test---which follows its prior antibody diagnostic test EUA.
If both tests are approved, GWHP could have the potential to emerge as a high-profile diagnostic testing company with one of the most diverse, rapid point-of-care (PoC) Covid-19 test portfolios in the market.
Here Are A Few Reasons Why Savvy Traders
Are About to Pounce On GWHP?
Imagine what it would be like? … going into the holiday season with another Multi-Bagger under your belt… imagine if you could increase your wealth by 10X TIMES!
Early investors typically grow their wealth—perhaps 10 times or more, when they're early. There really is no time to waste if you want to get positioned on the right side of the train, right?
Savvy investors succeed for a reason… they do their DD, and they get in early…
All this leads to one conclusion: people who pull up GWHP at this initial stage could be setting themselves up potentially for a major gain as the company becomes a significant player!
Because for all the reasons I’ve outlined, I am urging all of my members to add GWHP to the top of their watch list right now, and be ready Monday morning at the opening bell!
Your final step is to complete your research on GWHP before this weeks breakout.
I am urging all of my members to add GWHP to the top of their watch list right now, and be ready Monday morning at the opening bell!
Sincerely,
Editor In Chief, OTCtipReporter Team
